FDA faces backlash over approval of genetic test for opioid addiction risk

Posted on April 5, 2024 by blkalertshealth

The Food and Drug Administration is facing backlash over its approval of a genetic test intended to determine if a person is at increased risk for opioid addiction.

Posted in HealthTagged Black Health, black people health, blacknews, CNN, nbcnews, newswirelink, TIME, us health

Previous: Should you be worried about the bird flu? What experts say after Texas case

Next: Growing demand for stronger marijuana highlights the risk of cannabis-induced psychiatric disorders

Health

UnitedHealth paid ransom in Change Healthcare cyberattack, says patient data was compromised

blkalertshealth
April 24, 2024
0

UnitedHealth said it paid ransom to protect patien

Health

CDC describes first known cases of HIV transmitted via cosmetic injections

blkalertshealth
April 26, 2024
0

Three women likely got HIV while receiving “vampir

Health

What It’s Really Like to Have a 4-Day Workweek

blkalertshealth
April 13, 2024
0

To many people in corporate America, workin

New Comments

First Bullet Train Line Approved to Enter Service – BossFM Digital on First Bullet Train Line Approved to Enter Service
US Admitting Asylum Seekers, No Longer Enforcing “Remain in Mexico” Program – BossFM Digital on US Admitting Asylum Seekers, No Longer Enforcing “Remain in Mexico” Program
Moratorium Ending, Millions Face Eviction – BossFM Digital on Moratorium Ending, Millions Face Eviction
Journal of Neuroscience Study Finds Psychological Importance of Face-to-Face Interaction – BossFM Digital on Journal of Neuroscience Study Finds Psychological Importance of Face-to-Face Interaction

Related Posts

UnitedHealth paid ransom in Change Healthcare cyberattack, says patient data was compromised

CDC describes first known cases of HIV transmitted via cosmetic injections

What It’s Really Like to Have a 4-Day Workweek